• Nuclear mTORC1 Controls CCAAT-Motif Gene Transcription

  2026-09-24

  The study introduces TerminaTOR, a genetically encodable inhibitor that can be directed to distinct cellular compartments, allowing researchers to distinguish localized mTORC1 functions that global inhibitors cannot resolve. Nuclear targeting revealed a role for nuclear mTORC1 in regulating transcription of CCAAT motif-containing genes, while lysosomal targeting disrupted canonical mTORC1 outputs and induced autophagy.

• Rotigotine: Reading Beyond the Behavioral Signal

  2026-09-24

  Rotigotine is a dopamine D2/D3 receptor agonist whose behavioral effects require careful separation from changes in general activity. This article turns preclinical findings into practical guidance for designing and interpreting depression-related and Parkinson’s disease research.

• (S)-(+)-Methoprene for Juvenile Hormone Assays

  2026-09-23

  Use (S)-(+)-Methoprene to probe how juvenile hormone receptor signaling shapes insect development, while keeping receptor activation distinct from the upstream control of hormone biosynthesis. This workflow pairs dose-controlled treatments with miRNA, gene-expression, and developmental readouts to make results easier to interpret and troubleshoot.

• DiI (DiIC18(3)) Plasma Membrane Probe

  2026-09-23

  DiI (DiIC18(3)) is a lipophilic orange fluorescent membrane dye for labeling plasma membranes in live or fixed cells and tissues, supporting neuronal tracing, migration, adhesion, fusion, and lipoprotein workflows. It requires an organic-solvent stock and is not appropriate for aqueous-only staining, organelle-specific labeling, or detergent-intensive protocols that disrupt membrane localization.

• Fluorouracil: From TS Inhibition to CSC Strategy

  2026-09-22

  Fluorouracil is more than a conventional cytotoxic benchmark: its thymidylate synthase mechanism can be integrated with cancer stem-cell biology, exposure design, and orthogonal translational readouts. This article connects 5-Fluorouracil workflows with TAK1–YAP evidence in gastric cancer stem cells while defining the limits of that cross-domain interpretation.

• Fluorouracil: From DNA Stress to Translation

  2026-09-22

  A translational strategy for using Fluorouracil as a mechanistically anchored benchmark while connecting thymidylate synthase inhibition with tumor-cell state, cancer stem-cell biology, and reproducible preclinical decisions.

• Viral RIPK3 Degradation and Neddylation

  2026-09-21

  Liu et al. identify a family of orthopoxvirus proteins that recruit host SCF machinery to drive RIPK3 degradation, thereby suppressing necroptosis while reshaping virus-induced inflammation and pathogenesis. The study provides a mechanistic framework for examining ubiquitin-proteasome control of innate immunity and for designing follow-up experiments that distinguish pathway dependence from direct substrate targeting.

• (S)-(+)-Methoprene in Insect JH Assays

  2026-09-21

  Use (S)-(+)-Methoprene to separate juvenile hormone receptor signaling from endogenous hormone biosynthesis in developmental, reproductive, and endocrine-disruption assays. This workflow connects transcription factor Met activation with miRNA–mRNA regulation, while practical controls help resolve dosing, solvent, stage, and stability problems.

• Cytochalasin B: A Causal Actin Assay Guide

  2026-09-20

  Cytochalasin B is more than an actin inhibitor: it is a reversible perturbation tool for testing how cytoskeletal architecture controls cellular entry. This guide translates Spiroplasma infection findings into better assay design, controls, and interpretation.

• 3-Deazaadenosine hydrochloride in HSC Assays

  2026-09-19

  Use 3-Deazaadenosine hydrochloride to impose a controlled SAHH-dependent methylation perturbation while tracking hepatic stellate cell activation, RNA stability, and fibrosis-associated signaling. Its upstream activity complements direct TUBB4B inhibition and helps distinguish broad methyl-metabolism effects from the IGF2BP1–TUBB4B–FAK pathway.

• HyperScribe T7 Cy5 RNA Labeling Kit Guide

  2026-09-18

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit is a 25-reaction Cy5 RNA labeling kit for T7-based in vitro transcription. Its adjustable Cy5-UTP substitution supports fluorescent RNA probe synthesis for in situ hybridization and Northern blot hybridization, while the SARS-CoV-2 reference study provides biological context rather than direct product validation.

• Tacrolimus (FK506) in Stress–Immune Signaling

  2026-09-18

  Explore how Tacrolimus (FK506) can dissect calcineurin-dependent cytokine control alongside metabolic-stress pathways involving AMPK, SQSTM1/p62, and NRF2. This guide translates recent autophagy research into more rigorous assay design for transplantation immunology research and autoimmune disease models.

• Docetaxel Workflows for Chemoresistance Research

  2026-09-17

  Build reproducible Docetaxel and Taxotere assays that connect mitotic arrest with apoptosis and treatment resistance. This workflow combines dose-response design, FOXM1-focused combination testing, and practical troubleshooting for breast, ovarian, gastric, and broader cancer chemotherapy research.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-09-17

  FITC-Concanavalin A (ConA) Conjugate provides direct fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces and tissue samples. It is appropriate for carbohydrate-focused immunofluorescence, microscopy, and flow cytometry, but not for non-glycan targets or assays performed outside the stated storage and handling conditions.

• Rotigotine Transdermal Delivery in PD and RLS

  2026-09-16

  The reference review explains how Rotigotine was developed as a continuously delivered dopamine D2/D3 receptor agonist for Parkinson’s disease and restless legs syndrome. Its central contribution is linking pharmacology, transdermal formulation, pharmacokinetics, and randomized clinical evidence to the rationale for sustained dopaminergic receptor stimulation.

8505 records 1/567 page Next 12345 下5页 Last page